The Solus ALIF device, which is now available for commercial release in the U.S., features an integrated fixation method based on intellectual property previously acquired by the company. The patented fixation technology allows for enhanced segmental stability with a simplified surgical technique, while providing for substantial spacing to add bone graft.
Read the company news release about Alphatec Spine’s Solus ALIF device.
Read other coverage about Alphatec Spine:
– Alphatec Spine Receives CE Mark of Approval for Spinal Systems
– Alphatec Spine Reports 4Q Revenue of $46M, 38.4% Increase
– DJO Global CEO Leslie Cross Joins Alphatec Spine’s Board of Directors
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
